These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30406404)

  • 1. Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder.
    Nguyen L; Kakeda S; Katsuki A; Sugimoto K; Otsuka Y; Ueda I; Igata R; Watanabe K; Kishi T; Iwata N; Korogi Y; Yoshimura R
    Eur Arch Psychiatry Clin Neurosci; 2019 Oct; 269(7):785-794. PubMed ID: 30406404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder.
    Otsuka Y; Kakeda S; Sugimoto K; Katsuki A; Nguyen LH; Igata R; Watanabe K; Ueda I; Kishi T; Iwata N; Korogi Y; Yoshimura R
    Neuropsychiatr Dis Treat; 2019; 15():1537-1545. PubMed ID: 31239688
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI.
    Ide S; Kakeda S; Watanabe K; Yoshimura R; Abe O; Hayashi K; Ueda I; Kishi T; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J; Korogi Y
    Psychiatry Res; 2015 Aug; 233(2):120-4. PubMed ID: 26078197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the hippocampal shape abnormality and serum cortisol levels in first-episode and drug-naïve major depressive disorder patients.
    Watanabe R; Kakeda S; Watanabe K; Liu X; Katsuki A; Umeno-Nakano W; Hori H; Abe O; Yoshimura R; Korogi Y
    Depress Anxiety; 2017 May; 34(5):401-409. PubMed ID: 28129464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between interleukin (IL)-6 and brain morphology in drug-naïve, first-episode major depressive disorder using surface-based morphometry.
    Kakeda S; Watanabe K; Katsuki A; Sugimoto K; Igata N; Ueda I; Igata R; Abe O; Yoshimura R; Korogi Y
    Sci Rep; 2018 Jul; 8(1):10054. PubMed ID: 29968776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal subfield analysis in medication-naïve female patients with major depressive disorder.
    Han KM; Won E; Sim Y; Tae WS
    J Affect Disord; 2016 Apr; 194():21-9. PubMed ID: 26802503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM).
    Sajovic J; Cilenšek I; Mankoč S; Tajnšek Š; Kunej T; Petrovič D; Globočnik Petrovič M
    Bosn J Basic Med Sci; 2019 Feb; 19(1):94-100. PubMed ID: 30579324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TESC gene-regulating genetic variant (rs7294919) affects hippocampal subfield volumes and parahippocampal cingulum white matter integrity in major depressive disorder.
    Han KM; Won E; Kang J; Choi S; Kim A; Lee MS; Tae WS; Ham BJ
    J Psychiatr Res; 2017 Oct; 93():20-29. PubMed ID: 28575645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression.
    Phillips JL; Batten LA; Tremblay P; Aldosary F; Du L; Blier P
    Acta Neuropsychiatr; 2015 Dec; 27(6):353-61. PubMed ID: 25990886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal resting-state functional connectivity of hippocampal subfields in patients with major depressive disorder.
    Hao ZY; Zhong Y; Ma ZJ; Xu HZ; Kong JY; Wu Z; Wu Y; Li J; Lu X; Zhang N; Wang C
    BMC Psychiatry; 2020 Feb; 20(1):71. PubMed ID: 32066415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-related polymorphisms identified by GWAS and risk for major depression.
    Xie T; Stathopoulou MG; de Andrés F; Siest G; Murray H; Martin M; Cobaleda J; Delgado A; Lamont J; Peñas-LIedó E; LLerena A; Visvikis-Siest S
    Transl Psychiatry; 2017 Mar; 7(3):e1055. PubMed ID: 28267147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder.
    Hu X; Zhang L; Hu X; Lu L; Tang S; Li H; Bu X; Gong Q; Huang X
    J Magn Reson Imaging; 2019 Jun; 49(6):1760-1768. PubMed ID: 30295348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
    Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM
    Arch Gen Psychiatry; 2009 Jul; 66(7):721-8. PubMed ID: 19581563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction effects of oxytocin receptor gene polymorphism and depression on hippocampal volume.
    Na KS; Won E; Kang J; Kim A; Choi S; Kim YK; Lee MS; Ham BJ
    Psychiatry Res Neuroimaging; 2018 Dec; 282():18-23. PubMed ID: 30384146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.
    Sunada N; Takekita Y; Nonen S; Wakeno M; Koshikawa Y; Ogata H; Kinoshita T; Kato M
    Neuropsychobiology; 2019; 78(3):136-144. PubMed ID: 31189175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF)-related single nucleotide polymorphisms rs10738760 and rs6921438 are not associated with diabetic retinopathy (DR) in Slovenian patients with type 2 diabetes mellitus (T2DM).
    Terzić R; Cilenšek I; Zorc Pleskovič R; Mankoč S; Milutinović A
    Bosn J Basic Med Sci; 2017 Nov; 17(4):328-332. PubMed ID: 29055125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal subfield volumes in major depressive disorder and bipolar disorder.
    Han KM; Kim A; Kang W; Kang Y; Kang J; Won E; Tae WS; Ham BJ
    Eur Psychiatry; 2019 Apr; 57():70-77. PubMed ID: 30721801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases.
    Zaaber I; Rancier M; Stathopoulou MG; Saleh A; Marmouch H; Masson C; Murray H; Kurth MJ; Lamont J; Fitzgerald P; Mahjoub S; Said K; Bel Hadj Jrad Tensaout B; Mestiri S; Visvikis-Siest S
    Autoimmunity; 2016 Jun; 49(4):229-35. PubMed ID: 26955881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Combined Study of SLC6A15 Gene Polymorphism and the Resting-State Functional Magnetic Resonance Imaging in First-Episode Drug-Naive Major Depressive Disorder.
    Wang L; Liu Z; Cao X; Li J; Zhang A; Sun N; Yang C; Zhang K
    Genet Test Mol Biomarkers; 2017 Sep; 21(9):523-530. PubMed ID: 28915082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder.
    Han KM; Won E; Sim Y; Kang J; Han C; Kim YK; Kim SH; Joe SH; Lee MS; Tae WS; Ham BJ
    Sci Rep; 2017 Feb; 7():42621. PubMed ID: 28198448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.